Investigational new drug for Alzheimer's scheduled for first study in humans

(Vanderbilt University Medical Center) Vanderbilt University scientists have received notification from the US Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.